Coming EventsSee past events
1st European Alliance for Personalised Medicine Congress
Providing the right treatment at the right time to the right patient are precision medicine promises. With its cutting-edge activities in molecularly oriented clinical research, EORTC is at the forefront of the development of personalised medicine In Europe. EORTC Director General Denis Lacombe will present EORTC’s perspective during the Presidential Session “Shaping Future Healthcare and the One Health Agenda” on the 27th Nov during the European Alliance for Personalised Medicine (EAPM) congress entitled ‘Personalising Your Health: A Global Imperative!’ taking place in Belfast the 27-30 November 2017.
The EAPM brings together European healthcare experts and patient advocates involved with major chronic diseases. The aim is to improve patient care by accelerating the development, delivery and uptake of personalised medicine. A key aim of the Congress is to allow cross-fertilisation between the different disease and policy areas, allowing delegates to gain a greater depth of knowledge into barriers in the field of personalised medicine. It is also geared towards offering up valuable evidence and stakeholder opinion on which policy makers can base their decision making on how better to integrate personalised medicine into the EU’s healthcare services.
More information on the congress is available on the conference website.
Endocrine task Force Group meeting
We are pleased to announce you the Fall 2017 meeting of our taskforce on Tuesday November 28th 2017.
Drs Soares and Sobrinho-Simões invite you to the beautiful city of Porto, Portugal.
Please find the preliminary programme.
(5-1-1, chou-ku, Tsukiji, Tokyo, Japan)
Nowadays international collaborations are strategically important to take up the challenges of modern clinical research such as but not limited to multidisciplinary quality assurance programs and sub group fragmentation of diseases. Intercontinental academic trials between Europe and Asia are demanding but have been structuring and rewarding for knowledge development and cross expertise. Based on this shared vision, EORTC initiated a collaboration with the Japan Clinical Oncology Group (JCOG), the largest cancer research cooperative group in Japan and several projects including a research fellowship exchange program have already been ongoing.
As part of this partnership, a JCOG-EORTC symposium will take place in Tokyo, on 1-2 December, 2017. The purpose of this symposium is to deepen the mutual understanding about the current perspectives of both cooperative groups and strengthen this initiative in order to promote further collaborative projects which can impact on the larger number of cancer patients.